Guardant Health Inc. Common Stock vs Veeva Systems — how do they compare? Guardant Health Inc. Common Stock trades at $165.58 (market cap $22.58B), while Veeva Systems trades at $285.41 (market cap $45.74B). The key difference: Veeva Systems is far larger — about 2× Guardant Health Inc. Common Stock's market cap, and Guardant Health Inc. Common Stock is more actively traded (2,200,599 versus 1,118,315). Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| GH | VEEV | |
|---|---|---|
Market Cap | $22.58B | $45.74B |
Volume | 2,200,599 | 1,118,315 |
Sector | Health | Technology |
52-Week High | $187.22 | $299.10 |
52-Week Low | $61.73 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $23.22B | $38.65B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →